Liquid biopsy for nerve disorders linked to cancer
Part of Cancer clinical trials.
This study uses a blood test (liquid biopsy) to look for cancer-related signals in people with certain nerve disorders caused by the immune system (paraneoplastic neurological syndromes) or in people with tumors that do not affect the nerves. It aims to better understand and detect these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a nerve disorder (paraneoplastic neurological syndrome) with high- or intermediate-risk antibodies or GAD65-antibodies.
- Or you have a tumor outside the brain or spine (peripheral tumor) without any nerve disorder.
- You are 18 years or older.
- You are able to give informed consent.
- You do not have any reason that would prevent a blood draw (like a bleeding disorder or allergy to blood draw supplies).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at using a liquid biopsy (a simple test on spinal fluid) to find cancer DNA in the fluid around the brain and spine. The goal is to see if this test can guide more targeted treatment for cancers that have spread to the central nervous system.
This study looks at whether a simple blood test (called liquid biopsy) can help monitor how well your cancer treatment is working. By checking for tumor DNA in your blood before and during treatment, researchers hope to see if the treatment is effective and if the cancer is responding, which could help guide your care.
This trial is testing a blood test (liquid biopsy) to look for tiny traces of cancer DNA after surgery for pancreatic cancer. It may help doctors understand if the cancer is likely to come back.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
This study tests whether a blood test (liquid biopsy) can help doctors better understand your lung cancer and plan your treatment. You'll have a blood sample taken alongside standard biopsies to see if the blood test provides useful information about your cancer.
This trial checks whether a special blood test can help identify glioma (a type of brain tumor) that is new or coming back. It may help doctors learn more about the tumor using blood, alongside the usual brain scans and planned surgery.
Hear when a new Paraneoplastic Neurological Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.